Posts by ericg
Vertex makes room in its C-suite for new technical operations role
Vertex Pharmaceuticals Inc. has promoted E. Morrey Atkinson to a new role in its C-suite: chief technical operations officer. Read More
Read MoreSecond wind developer moves to terminate contracts
SouthCoast Wind will to pay utility companies $60 million to terminate contracts the parties previously struck for the clean energy. Read More
Read MoreWatertown software founder takes on Boston traffic with new water shuttle
The idea for building a water shuttle for the Charles River came to Drew Rollert as one might expect: After a particularly terrible attempt to get around in Greater Boston. The "Wada Hoppah" will ferry riders between Watertown and Boston’s Hatch Shell. Read More
Read MoreCommentary: What access to higher ed means to undocumented youth and their communities
A local leader writes that providing in-state tuition for all Mass. high school graduates, regardless of immigration status, not only is long overdue but also has major benefits for everyone. Read More
Read MoreFinally, a downtown Boston office building trades hands
The $41 million sale offers hope to property owners that the city’s stagnant office market, frozen by rising interest rates, high vacancies and fear of a hybrid-work future, may finally start seeing some action. Read More
Read MoreA shrine to ice cream coming to the Seaport, and other retail and restaurant news
For fans of ice cream and Instagram-worthy destinations, the Museum of Ice Cream is coming to the Seaport. Read More
Read MoreCognex goes deeper into Japanese market with $275M acquisition
Cognex Corp. is deepening its penetration of the Japanese market thanks to what it described as its "largest acquisition in its 42-year history." Read More
Read MoreApellis to lay off 225 amid shaky drug launch
A Waltham biotech is laying off 225 people amid safety concerns over its new eye-disorder drug. Read More
Read MoreEmbattled Intarcia drug licensed to Harvard spinout, with Intarcia CEO Kurt Graves at the helm
Years after it went silent in the wake of multiple FDA rejections, Intarcia Therapeutics is effectively back. Read More
Read MoreNew England Law settles over improper federal student loan claims
Five law schools across the U.S., including one based in Boston, have reached a $2.9 million settlement with the U.S. Department of Education after an investigation revealed that the schools improperly gave federal student loans to student enrolled in unaccredited law degree programs. Read More
Read More